Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 3,458 | 4,466 | -3,990 | 16,004 | 5,135 |
| Operating Income | -3,458 | -4,466 | 3,990 | -16,004 | -5,135 |
| Interest Expense | 24 | 17 | 1,765 | 223 | 148 |
| Other Income | 1,067 | 702 | 2,979 | 1,109 | 123 |
| Pre-tax Income | -2,415 | -3,781 | 5,204 | -15,118 | -5,160 |
| Net Income Continuous | -2,415 | -3,781 | 5,204 | -15,118 | -5,160 |
| Minority Interests | -10 | -19 | 16 | -66 | -22 |
| Net Income | $-2,405 | $-3,762 | $5,188 | $-15,052 | $-5,138 |
| EPS Basic Total Ops | -1.80 | -2.80 | 6.51 | -14.47 | -5.00 |
| EPS Basic Continuous Ops | -1.75 | -2.79 | 6.28 | -14.47 | -4.91 |
| EPS Diluted Total Ops | -1.80 | -2.80 | 6.51 | -14.47 | -5.00 |
| EPS Diluted Continuous Ops | -1.75 | -2.79 | 6.28 | -14.47 | -4.91 |
| EPS Diluted Before Non-Recurring Items | -1.60 | -3.20 | -6.40 | N/A | N/A |
| EBITDA(a) | $-3,409 | $-4,418 | $4,038 | $-15,954 | $-5,082 |